Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 4/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7419765 | 0.94 | PLA2G2A (0.39) | PLA2G2AFABP4NPC1DPP4PPARG | |
| SCHEMBL7470934 | 0.90 | PLA2G2A (0.38) | PLA2G2AALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL7476214 | 0.89 | PLA2G2A (0.51) | PLA2G2ANPC1DPP4PPARGPPARD | |
| SCHEMBL7472399 | 0.88 | ALDH1A1 (0.39) | PLA2G2AALDH1A1KDM4ENPC1 | |
| SCHEMBL7418369 | 0.88 | PLA2G2A (0.48) | PLA2G2AFABP4AGTR1AGTR2PPARG | |
| SCHEMBL7422125 | 0.87 | AGTR1 (0.39) | PLA2G2AALDH1A1FOLH1AGTR1AGTR2 | |
| SCHEMBL7420760 | 0.87 | PLA2G2A (0.38) | PLA2G2AAGTR1AGTR2HPGDNPC1 | |
| Hydrochloric Acid SCHEMBL7418164 | 0.87 | PLA2G2A (0.38) | PLA2G2ANPC1DPP4 | |
| SCHEMBL29611861 | 0.87 | ALOX5AP (0.47) | PLA2G2AALDH1A1KDM4EDPP4PPARG | |
| SCHEMBL7481829 | 0.87 | MAPT (0.41) | PLA2G2AALDH1A1KDM4EAGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0820441-B1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-6358992-B1 | Method of inhibiting neoplastic cells with indole derivatives | CELL PATHWAYS, INC. | 2002-03-19 | — | — | US | disclosed |
| US-6069156-A | Indole derivatives as cGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-30 | — | — | US | disclosed |
| CN-1187812-A | Indole derivatives as CGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-07-15 | — | — | CN | disclosed |
| EP-0820441-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032379-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-17 | — | — | WO | disclosed |